Dear delegates, keynote speakers, and sponsors,

On behalf of the 23^rd ICRAV Organising Committee, we would like to express our heartfelt gratitude for your invaluable contributions to the success of this conference. Your enthusiasm and active involvement have greatly contributed to the vibrant atmosphere throughout the event. Although the conference has now concluded, we encourage you to remain engaged by taking advantage of the following opportunities:

Conference app - Whova

To facilitate ongoing communication and networking, the conference app will remain accessible for an additional three months until 23 December 2023. We would like to highlight some important information and arrangements regarding the app:

1. Photos: All existing photos in the app will be replaced with new official conference photos by the Event Manager on 11 October 2023. If you have any photos that you would like to keep, please archive them from the app before this date.
2. Live Q&A: This feature allows attendees to ask questions during or after specific scientific sessions. Speakers can access the questions directed at their presentations through the “Speaker Hub” and can respond directly in the app or via email. Feel free to continue posting new questions for speakers under the relevant scientific sessions.
3. Exporting information: Under the profile menu, you have the option to export the contacts you’ve exchanged and the notes you’ve taken under “My Contacts” and “My Notes” respectively. This allow you to save this information by sending it to your registered email.

23^rd ICRAV Proceedings and special issue of Drug Testing and Analysis

The Organising Committee eagerly awaits the submission of manuscripts based on the presentations made during the conference. Please note that the deadline for manuscript submission is 30 November 2023. Author guidelines for publication can be found on the conference website: https://www.icrav2023.com/en/author-guidelines. Furthermore, selected manuscripts submitted to the conference proceedings before the deadline may be invited to submit to a special issue of the international peer-reviewed scientific journal, Drug Testing and Analysis (DTA), specifically dedicated to the 23^rd ICRAV.

Once again, we extend our heartfelt appreciation for your participation and support. We hope that you will continue to engage with the conference proceedings and take advantage of the opportunities presented by the conference app and the special issue of DTA.

Kind Regards,

Emmie Ho

Chair of the 23^rd ICRAV Organising Committee